Benzinga - by Avi Kapoor, Benzinga Staff Writer.
GitLab Inc. (NASDAQ: GTLB) is expected to release earnings results for its fourth quarter, after the closing bell on March 4, 2024.
Analysts expect the San Francisco, California-based company to report a quarterly earnings at 8 cents per share, versus a year-ago loss of 3 cents per share. GitLab is projected to post revenue of $158.21 million for the latest quarter, compared to $122.91 million in the year-earlier quarter, according to data from Benzinga Pro.
On Jan. 18, GitLab named Sabrina Farmer as its chief technology officer (CTO).
GitLab shares gained 1.7% to close at $73.31 on Friday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- Truist Securities analyst Barry Jonas maintained a Buy rating and raised the price target from $75 to $80 on Feb. 20, 2024. This analyst has an accuracy rate of 63%.
- DA Davidson analyst Gil Luria maintained a Neutral rating and boosted the price target from $60 to $75 on Feb. 5, 2024. This analyst has an accuracy rate of 75%.
- Mizuho analyst Gregg Moskowitz upgraded the stock from Neutral to Buy with a price target of $73 on Jan. 8, 2024. This analyst has an accuracy rate of 74%.
- Goldman Sachs analyst Kash Rangan maintained a Buy rating and boosted the price target from $70 to $80 on Dec. 6, 2023. This analyst has an accuracy rate of 66%.
- RBC Capital analyst Matthew Hedberg maintained an Outperform rating and raised the price target from $62 to $70 on Dec. 6, 2023. This analyst has an accuracy rate of 78%.
Read This Next: Jim Cramer Says This Is A 'Smart Consulting Company,' Calls Commercial Metals Company A Winner
Latest Ratings for GTLB
| Mar 2022 | B of A Securities | Maintains | Buy | |
| Feb 2022 | RBC Capital | Upgrades | Sector Perform | Outperform |
| Jan 2022 | JP Morgan | Upgrades | Neutral | Overweight |
View the Latest Analyst Ratings
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.